目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 MARKET SCOPE
1.6 SUMMARY OF CHANGES
1.6.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET RANKING ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 LIMITATIONS
2.8 GROWTH RATE ASSUMPTIONS
2.9 RECESSION IMPACT ON WOUND CARE MARKET

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 PRICING ANALYSIS
5.3.1 AVERAGE SELLING PRICE TREND, BY REGION
5.3.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
5.4 CASE STUDY ANALYSIS
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 PORTER'S FIVE ANALYSIS
5.8 ECOSYSTEM ANALYSIS OF THE GLOBAL WOUND CARE MARKET
5.9 PESTLE ANALYSIS
5.10 TARIFF & REGULATORY LANDSCAPE
5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES & OTHER ORGANIZATIONS
5.11 PATENT ANALYSIS
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESS
5.13 KEY CONFERENCES & EVENTS IN 2023-2024
5.14 TECHNOLOGY ANALYSIS
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.16 TRADE ANALYSIS
5.16.1 IMPORT SCENARIO
5.16.2 EXPORT SCENARIO

6 WOUND CARE MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 ADVANCED WOUND CARE PRODUCTS
6.2.1 ADVANCED WOUND DRESSINGS BY TYPE
6.2.1.1 FOAM DRESSINGS
6.2.1.1.1 SILICONE DRESSINGS
6.2.1.1.2 NON-SILICONE DRESSINGS
6.2.1.2 HYDROCOLLOID DRESSINGS
6.2.1.3 FILM DRESSINGS
6.2.1.4 ALGINATE DRESSINGS
6.2.1.5 HYDROGEL DRESSINGS
6.2.1.6 COLLAGEN DRESSINGS
6.2.1.7 HYDROFIBER DRESSINGS
6.2.1.8 WOUND CONTACT LAYERS
6.2.1.9 SUPERABSORBENT DRESSINGS
6.2.1.12 OTHER ADVANCED WOUND CARE DRESSINGS
6.2.2 ADVANCED WOUND DRESSINGS BY PROPERTIES
6.2.2.1 NON-ANTIMICROBIAL DRESSINGS
6.2.2.2 ANTIMICROBIAL DRESSINGS
6.2.3 WOUND THERAPY DEVICES
6.2.3.1 PORTABLE & CONVENTIONAL NPWT DEVICES
6.2.3.2 DEBRIDEMENT DEVICES & ACCESSORIES
6.2.3.3 WOUND ASSESSMENT & MONITORING DEVICES
6.2.3.4 OTHER DEVICES & ACCESSORIES
6.2.4 BIOLOGICAL SKIN SUBSTITUTES
6.2.4.1 HUMAN DONOR TISSUE-DERIVED PRODUCTS
6.2.4.2 ACELLULAR ANIMAL-DERIVED PRODUCTS
6.2.4.3 BIOSYNTHETIC PRODUCTS
6.2.5 TOPICAL AGENTS
6.3 SURGICAL WOUND CARE PRODUCTS
6.3.1 SUTURES
6.3.2 TISSUE ADHESIVES, SEALANTS, AND GLUES
6.3.2.1 FIBRIN-BASED SEALANTS
6.3.2.2 SYNTHETIC ADHESIVES
6.3.2.3 COLLAGEN-BASED SEALANTS
6.3.3 STAPLERS
6.4 TRADITIONAL WOUND CARE PRODUCTS
6.4.1 MEDICAL TAPES
6.4.2 DRESSINGS
6.4.3 CLEANSING AGENTS

7 WOUND CARE MARKET, BY WOUND TYPE
7.1 INTRODUCTION
7.2 ACUTE WOUNDS
7.2.1 SURGICAL & TRAUMATIC WOUNDS
7.2.2 BURNS & OTHER ACUTE WOUNDS
7.3 CHRONIC WOUNDS
7.3.1 DIABETIC FOOT ULCERS
7.3.2 PRESSURE ULCERS
7.3.3 VENOUS LEG ULCERS
7.3.4 OTHER CHRONIC WOUNDS

8 WOUND CARE MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS & CLINICS
8.2.1 INPATIENT SETTINGS
8.2.2 OUTPATIENT SETTINGS
8.3 HOME CARE SETTINGS
8.4 LONG-TERM CARE FACILITIES
8.5 OTHER END USERS

9 WOUND CARE MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 RECESSION IMPACT
9.2.2 US
9.2.3 CANADA
9.3 EUROPE
9.3.1 RECESSION IMPACT
9.3.2 GERMANY
9.3.3 UK
9.3.4 FRANCE
9.3.5 ITALY
9.3.6 SPAIN
9.3.7 RUSSIA
9.3.8 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 RECESSION IMPACT
9.4.2 JAPAN
9.4.3 CHINA
9.4.4 INDIA
9.4.5 AUSTRALIA
9.4.6 SOUTH KOREA
9.4.7 SINGAPORE
9.4.8 REST OF APAC
9.5 LATIN AMERICA
9.5.1 RECESSION IMPACT
9.5.2 BRAZIL
9.5.3 MEXICO
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 RECESSION IMPACT

10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
10.3 MARKET SHARE ANALYSIS
10.3.1 WOUND CARE MARKET
10.3.1.1 ADVANCED WOUND CARE
10.3.1.2 NEGATIVE PRESSURE WOUND THERAPY
10.3.1.3 ADVANCED WOUND DRESSINGS
10.3.1.4 SURGICAL SUTURES
10.3.1.5 DEBRIDEMENT DEVICES
10.3.1.6 TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS MARKET
10.4 REVENUE ANALYSIS
10.5 COMPANY EVALUATION MATRIX
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT
10.6 START-UP/SME EVALUATION MATRIX
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING
10.7 COMPETITIVE SCENARIO
10.7.1 PRODUCT LAUNCHES
10.7.2 DEALS

11 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 KEY PLAYERS
11.1.1 3M GROUP
11.1.2 CARDINAL HEALTH
11.1.3 MEDTRONIC PLC
11.1.4 B. BRAUN MELSUNGEN AG
11.1.5 SMITH & NEPHEW PLC
11.1.6 MÖLNLYCKE HEALTH CARE AB
11.1.7 PAUL HARTMANN AG
11.1.8 CONVATEC GROUP
11.1.9 ZIMMER BIOMET HOLDINGS INC.
11.1.10 BAXTER INTERNATIONAL, INC.
11.1.11 ORGANOGENESIS HOLDINGS INC.
11.1.12 INTEGRA LIFESCIENCES HOLDING CORPORATION
11.1.13 COLOPLAST A/S
11.1.14 MIMEDX GROUP
11.1.15 BIOVENTUS
11.2 OTHER PLAYERS
11.2.1 ETHICON, INC.
11.2.2 DEROYAL INDUSTRIES
11.2.3 KERECIS
11.2.4 CARILEX MEDICAL
11.2.5 LOHMANN & RAUSCHER INTERNATIONAL GMBH & CO.
11.2.6 MEDELA AG
11.2.7 TALLEY GROUP
11.2.8 WELCARE INDUSTRIES SPA
11.2.9 WUHAN VSD MEDICAL SCIENCE & TECHNOLOGY CO., LTD
11.2.10 PENSAR MEDICAL
11.2.11 HAROMED BV
11.2.12 DERMARITE INDUSTRIES LLC
11.2.13 MEDLINE INDUSTRIES, INC.
11.2.14 ADVANCIS MEDICAL LLC
11.2.15 MIL LABORATORIES PVT. LTD
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKET'S SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS